Related references
Note: Only part of the references are listed.Macrophages, Inflammation, and Insulin Resistance
Jerrold M. Olefsky et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity
Adeline Bertola et al.
DIABETES (2009)
Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal Muscle
Eun-Gyoung Hong et al.
DIABETES (2009)
12/15-Lipoxygenase Is Required for the Early Onset of High Fat Diet-Induced Adipose Tissue Inflammation and Insulin Resistance in Mice
Dorothy D. Sears et al.
PLOS ONE (2009)
Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization
D. D. Sears et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Osteopontin expression in human and murine obesity: Extensive local up-regulation in adipose tissue but minimal systemic alterations
Florian W. Kiefer et al.
ENDOCRINOLOGY (2008)
Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells
Mari L. Shinohara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inflammation and insulin resistance
Carl de Luca et al.
FEBS LETTERS (2008)
Adipocyte death, adipose tissue remodeling, and obesity complications
Katherine J. Strissel et al.
DIABETES (2007)
A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways
M. T. Audrey Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice
Takashi Nomiyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Osteopontin is associated with nuclear factor κB gene expression during tail-suspension-induced bone loss
Muneaki Ishijima et al.
EXPERIMENTAL CELL RESEARCH (2006)
Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2-/- mice
Dympna Harmey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The metabolic syndrome and adipocytokines
Yuji Matsuzawa
FEBS LETTERS (2006)
Playing with bone and fat
JM Gimble et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
A pericellular collagenase directs the 3-dimensional development of white adipose tissue
Tae-Hwa Chun et al.
CELL (2006)
From big fat cells to high blood pressure: a pathway to obesity-associated hypertension
Z Pausova
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Intracellular signalling pathways activated by leptin
G Fruhbeck
BIOCHEMICAL JOURNAL (2006)
Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1
Anita M. Hennige et al.
FASEB JOURNAL (2006)
Mechanisms of disease: is osteoporosis the obesity of bone?
CJ Rosen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice
SY Park et al.
DIABETES (2005)
Long-term prospective and controlled studies demonstrate adipose tissue hypercellularity and relative leptin deficiency in the postobese state
P Löfgren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
S Cinti et al.
JOURNAL OF LIPID RESEARCH (2005)
Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications
B Christensen et al.
BIOCHEMICAL JOURNAL (2005)
PPARs: therapeutic targets for metabolic disease
JP Berger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Liver X receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways
D Ogawa et al.
CIRCULATION RESEARCH (2005)
ΔFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms
M Kveiborg et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
PPARs and the complex journey to obesity
RM Evans et al.
NATURE MEDICINE (2004)
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle
JK Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs)
I Sekiya et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model
A Sahai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Gene expression profiling of potential PPARγ target genes in mouse aorta
HL Keen et al.
PHYSIOLOGICAL GENOMICS (2004)
Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis:: role of short-form leptin receptors and osteopontin
A Sahai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue
RH Lee et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2004)
The role of osteopontin in tumor metastasis
PY Wai et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice
D Bruemmer et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Role of leptin as an immunomodulator of blood mononuclear cells:: mechanisms of action
V Sánchez-Margalet et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Notch 1 impairs osteoblastic cell differentiation
M Sciaudone et al.
ENDOCRINOLOGY (2003)
A new selective peroxisome proliferator-activated receptor γ antagonist with antiobesity antidiabetic activity
J Rieusset et al.
MOLECULAR ENDOCRINOLOGY (2002)
Microarray analyses during adipogenesis:: Understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor α in adipocyte metabolism
SE Ross et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
PPARγ ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells
Y Oyama et al.
CIRCULATION RESEARCH (2002)
Mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance.
T Yamauchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male Wistar rats
AL Hevener et al.
DIABETES (2001)
Role of osteopontin in cellular signaling and toxicant injury
DT Denhardt et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
JM Olefsky
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
